Core Viewpoint - A groundbreaking oral nutritional supplement, "Dr. End PQQ Dihydroquercetin Compound Peptide Effervescent Tablets," developed by the Seiko Telomere Programming Laboratory in collaboration with Harvard Anti-Aging and Anti-Cancer Research Center, is set to launch globally in August 2025, marking a significant advancement in the field of immune modulation and anti-aging cancer prevention [1][7]. Group 1: Product Development and Technology - The product utilizes "Functional Modulation NK Cells" technology to precisely regulate the activity of endogenous NK cells, aiming to restore immune balance and address the decline in NK cell quantity and activity due to aging and environmental factors [3][5]. - The supplement is backed by multiple top-tier invention patents, with international patents in the anti-aging and anti-cancer fields already granted, establishing a strong technological barrier and global leadership [1][5]. Group 2: Clinical Trials and Efficacy - A clinical trial involving 586 participants aged 45-65 demonstrated a significant increase in endogenous NK cell quantity and activity, with an average improvement rate of 21.3% after 24 weeks of continuous use [5]. - The product's safety and reliability are enhanced as it activates the body's endogenous NK cells without external interference, contrasting with the risks associated with exogenous NK cell activation therapies [5][6]. Group 3: Market Launch and Global Impact - The product will be marketed globally by Seiko Pharmaceutical Technology (Jiangsu) Co., Ltd., through the "Dr. End Health Happy Mall," highlighting a milestone in the biopharmaceutical industry and a historic breakthrough in immune modulation and anti-aging cancer prevention [7]. - This launch is expected to inject significant momentum into global health and well-being, ushering in a new era of precise immune protection [7].

Core Viewpoint - The successful development of the world's first "functional modulation" NK cell oral dietary supplement by the company fills a global technological gap in immune health and cancer prevention [1][10]. Group 1: NK Cell Importance and Challenges - NK cells are essential components of the innate immune system, responsible for quickly identifying and eliminating cancerous and virus-infected cells, thus playing a crucial role in cancer and virus resistance, chronic inflammation improvement, and immune enhancement [3]. - Factors such as aging, work stress, environment, and diet lead to a significant decline in the body's endogenous NK cell count, which increases the risk of cancer and viral infections [3][5]. - Overactivation of NK cells can cause various health issues, including autoimmune diseases, chronic inflammation, pregnancy complications, tumor immune evasion, and neurodegenerative disorders like Alzheimer's [3][5]. Group 2: "Functional Modulation" NK Cell Technology - "Functional modulation" of NK cells aims to reduce the activity of overactive or dysfunctional NK cells to restore immune balance, which is critical for maintaining health [5]. - The technology is considered a global research hotspot due to its potential to safely activate endogenous NK cells through oral supplements, avoiding risks associated with exogenous NK cell therapies [6]. Group 3: Research and Clinical Trials - The research team at the company, in collaboration with Harvard's anti-aging and cancer prevention research center, conducted a 76-week study using natural ingredients to create the oral supplement [8]. - Clinical trials involving 586 participants aged 45-65 showed a significant increase in endogenous NK cell counts by 17.5%-23.7%, with an average growth rate of 21.3% after 24 weeks of continuous use [8]. - The research results have been submitted for international invention patent protection [8]. Group 4: Product Launch and Future Prospects - The research findings have been licensed to a pharmaceutical company for global promotion, with the product tentatively named "Dr. Duan POQ Dihydroquercetin Compound Protein Peptide Effervescent Tablets" [10]. - The innovative product is expected to bring significant health benefits to humanity upon its market launch [10].